CALCULATE YOUR SIP RETURNS

Indoco Remedies Partners with Clarity Pharma for UK Expansion

Updated on: Dec 3, 2024, 3:01 PM IST
Indoco Remedies partners with Clarity Pharma, UK, to launch 20 products in 18 months, leveraging their global expertise and strong healthcare networks.
Indoco Remedies Partners with Clarity Pharma for UK Expansion
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Indoco Remedies has announced a strategic partnership with Clarity Pharma, UK, marking a key milestone in its expansion efforts. Under this collaboration, Indoco plans to launch around 20 products in the next 18 months through Clarity Pharma, its distributor in the UK. The company will also maintain its existing B2B partnerships, ensuring continuity in product supply to its global clients.

Indoco Remedies is a fully integrated, research-driven pharmaceutical company with a turnover of $212 million. It boasts a strong global presence and employs over 6,000 individuals, including 400 skilled scientists and field staff.

Clarity Pharma’s Expertise

Clarity Pharma brings over 25 years of experience in market launches, serving more than 4,000 primary healthcare customers in the UK. This collaboration is expected to leverage both companies’ strengths, driving growth and innovation in the pharmaceutical sector.

Commenting on this partnership, the Managing Director of Indoco Remedies Ltd, Ms Aditi Panandikar, said, “This collaboration with Clarity Pharma is a significant milestone for Indoco as this will further strengthen our foothold in the UK pharma market. By combining Indoco’s robust portfolio of high-quality, affordable pharmaceutical products with Clarity Pharma’s strong distribution network and market expertise, we are poised to deliver innovative healthcare solutions to a broader patient base.”

Mr Steve Soper, CEO of Clarity Pharma stated, ‘Today is the beginning of a truly exciting journey between Indoco and Clarity and is the result of several years of hard work in putting this market access project together. The range of Indoco products is exciting and extensive and will deliver significant savings to the market once launched, we look forward to a bright future of collaboration, growth, and making a difference in the affordability of a wide range of medicines.”

On December 3, 2024, Indoco Remedies share price opened at ₹349.00, touching the day’s high at ₹355.00, as of 9:46 AM on the NSE.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.

Published on: Dec 3, 2024, 12:00 PM IST

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2.5 Cr+ happy customers